Certified by Founder
Lodge
Hyperscience
start up
United States
- New York, New York
- 22/12/2021
- Series E
- $100,000,000
Hyperscience is transforming the future of work to elevate human potential. Our human-centered approach to automation enables a new era of human and machine collaboration that delivers dramatically improved organizational agility, without the legacy cost and burden of change management. By combining data, people, and processes into digital assembly lines, the Hyperscience Platform turns complex processes into simple, configurable workflows. Our industry-leading machine learning technology continuously learns and evolves, to involve humans only when needed.
- Industry Software Development
- Website https://hyperscience.com/
- LinkedIn https://www.linkedin.com/company/hyperscience/about/
Atlas Invest | $25,000,000 | (Jan 22, 2026)
AiStrike | $7,000,000 | (Jan 22, 2026)
Zarminali Pediatrics | $110,000,000 | (Jan 22, 2026)
AnswersNow | $40,000,000 | (Jan 22, 2026)
Upscale AI(US) | $200,000,000 | (Jan 22, 2026)
Nasdaq Private Market | $37,600,000 | (Jan 22, 2026)
PraxisPro | $6,000,000 | (Jan 22, 2026)
furl | $10,000,000 | (Jan 22, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
ErVimmune | $19,917,795 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)